Assembly Biosciences Inc. (NASDAQ:ASMB) went up by 1.31% from its latest closing price compared to the recent 1-year high of $7.02. The company’s stock price has collected -6.83% of loss in the last five trading sessions. Press Release reported on 11/12/21 that Assembly Biosciences Presents New Data at AASLD The Liver Meeting(TM) Highlighting the Progress of its HBV Core Inhibitor Portfolio
Is It Worth Investing in Assembly Biosciences Inc. (NASDAQ :ASMB) Right Now?
Plus, the 36-month beta value for ASMB is at 0.62. Opinions of the stock are interesting as 2 analysts out of 7 who provided ratings for Assembly Biosciences Inc. declared the stock was a “buy,” while 1 rated the stock as “overweight,” 4 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $9.58, which is $7.26 above the current price. ASMB currently public float of 40.52M and currently shorts hold a 3.46% ratio of that float. Today, the average trading volume of ASMB was 753.57K shares.
ASMB’s Market Performance
ASMB stocks went down by -6.83% for the week, with a monthly drop of -24.68% and a quarterly performance of -37.13%, while its annual performance rate touched -57.97%. The volatility ratio for the week stands at 6.06% while the volatility levels for the past 30 days are set at 4.45% for Assembly Biosciences Inc.. The simple moving average for the period of the last 20 days is -19.08% for ASMB stocks with a simple moving average of -40.51% for the last 200 days.
Analysts’ Opinion of ASMB
Many brokerage firms have already submitted their reports for ASMB stocks, with H.C. Wainwright repeating the rating for ASMB by listing it as a “Neutral.” The predicted price for ASMB in the upcoming period, according to H.C. Wainwright is $3.50 based on the research report published on September 13th of the current year 2021.
ASMB Trading at -25.71% from the 50-Day Moving Average
After a stumble in the market that brought ASMB to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -66.95% of loss for the given period.
Volatility was left at 4.45%, however, over the last 30 days, the volatility rate increased by 6.06%, as shares sank -25.16% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -27.50% lower at present.
During the last 5 trading sessions, ASMB fell by -6.83%, which changed the moving average for the period of 200-days by -64.80% in comparison to the 20-day moving average, which settled at $2.83. In addition, Assembly Biosciences Inc. saw -61.65% in overturn over a single year, with a tendency to cut further losses.
Reports are indicating that there were more than several insider trading activities at ASMB starting from McHutchison John G, who sale 12,156 shares at the price of $3.60 back on Aug 09. After this action, McHutchison John G now owns 125,693 shares of Assembly Biosciences Inc., valued at $43,781 using the latest closing price.
Delaney William E IV, the Chief Scientific Officer of Assembly Biosciences Inc., sale 4,129 shares at $4.03 during a trade that took place back on May 27, which means that Delaney William E IV is holding 53,121 shares at $16,637 based on the most recent closing price.
Stock Fundamentals for ASMB
Current profitability levels for the company are sitting at:
- -81.89 for the present operating margin
The net margin for Assembly Biosciences Inc. stands at -78.57. The total capital return value is set at -24.16, while invested capital returns managed to touch -23.47. Equity return is now at value -46.20, with -40.60 for asset returns.
Based on Assembly Biosciences Inc. (ASMB), the company’s capital structure generated 4.21 points at debt to equity in total, while total debt to capital is 4.04. Total debt to assets is 3.49, with long-term debt to equity ratio resting at 2.80. Finally, the long-term debt to capital ratio is 2.68.
When we switch over and look at the enterprise to sales, we see a ratio of -13.06, with the company’s debt to enterprise value settled at 1.26. The receivables turnover for the company is 34.36 and the total asset turnover is 0.25. The liquidity ratio also appears to be rather interesting for investors as it stands at 9.19.